Home > Financial Ratios > JENBURKT PHARMACEUTICALS

JENBURKT PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
JENBURKT PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for JENBURKT PHARMACEUTICALS
Please provide your vote to see the results

JENBURKT PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 6.4710.2133.350.78-15.54

What is the latest Core EBITDA Growth ratio of JENBURKT PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JENBURKT PHARMACEUTICALS is 6.47 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar20246.47
Mar202310.21
Mar202233.35
Mar20210.78
Mar2020-15.54

How is Core EBITDA Growth of JENBURKT PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2024 6.47
-36.63
Mar2023 10.21
-69.39
Mar2022 33.35
4,175.64
Mar2021 0.78
Positive
Mar2020 -15.54 -

Other Financial Ratios of JENBURKT PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JENBURKT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS ₹528.1 Cr -2% -1.5% 42.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹431,400.0 Cr 2% -0.9% 31.9% Stock Analytics
DIVIS LABORATORIES ₹154,622.0 Cr -1.6% -0.4% 57.3% Stock Analytics
CIPLA ₹116,240.0 Cr -0.3% -2.5% 7.9% Stock Analytics
DR REDDYS LABORATORIES ₹108,166.0 Cr -0.5% -3.3% 14% Stock Analytics
ZYDUS LIFESCIENCES ₹98,495.2 Cr -1% 0.6% 39.1% Stock Analytics


JENBURKT PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JENBURKT PHARMACEUTICALS

-2%

-1.5%

42.8%

SENSEX

-0.4%

-2.1%

6.9%


You may also like the below Video Courses